Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Leukemia

Free Subscription Articles published in Am J Hematol Retrieve available abstracts of 72 articles: HTML format Text format

Single Articles

February 2010
1. BULDINI B , Zangrando A, Michielotto B, Veltroni M, et al
   Identification of immunophenotypic signatures by clustering analysis in pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
   Am J Hematol. 2010;85:138-41.
   PubMed     Text format     Related articles   
   
   
   
2. KLCO JM , Geng B, Brunt EM, Hassan A, et al
   Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility.
   Am J Hematol. 2010;85:106-10.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. DEMING D , Silverman E
   Pasteurella multocida tracheobronchitis in a patient with CLL on rituximab.
   Am J Hematol. 2010;85:144-5.
   PubMed     Text format     Related articles   
   
   
   January 2010
4. FULLMER A , Cortes J, Kantarjian H, Jabbour E, et al
   ASH 2009 meeting report-Top 10 clinically oriented abstracts in chronic myeloid leukemia.
   Am J Hematol. 2010.
   PubMed     Text format     Related articles   
   
   
   
5. FULLMER A , Jabbour E
   Treatment of Philadelphia-positive acute lymphocytic leukemia with tyrosine kinase inhibitors: What is the optimal regimen?
   Am J Hematol. 2010.
   PubMed     Text format     Related articles   
   
   
   
6. FULLMER A , Cortes J, Kantarjian H, Jabbour E, et al
   ASH 2009 meeting report-Top 10 clinically oriented abstracts in acute leukemia.
   Am J Hematol. 2010.
   PubMed     Text format     Related articles   
   
   
   
7. O'BRIEN S
   ASH 2009 meeting report-Top 10 clinically oriented abstracts in chronic lymphocytic leukemia.
   Am J Hematol. 2010;85:207-210.
   PubMed     Text format     Related articles   
   
   
   December 2009
8. LILLY MB , Ottmann OG, Shah NP, Larson RA, et al
   Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study.
   Am J Hematol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
9. MA X , Wu D, Sun A, Qiu H, et al
   The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
   Am J Hematol. 2009.
   PubMed     Text format     Related articles   
   
   
   September 2009
10. PAPAYANNIDIS C , Derenzini E, Iacobucci I, Curti A, et al
    Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
11. MARTIN MG , Augustin KM, Uy GL, Welch JS, et al
    Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. POHLMANN R , Bhargava P
    Acute monoblastic leukemia with abnormal granules and disseminated intravascular coagulation: Diagnostic pitfalls.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    August 2009
13. BATZIOS C , Hayes LA, He SZ, Quach H, et al
    Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. GEMMATI D , De Mattei M, Catozzi L, Della Porta M, et al
    DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing?
    Am J Hematol. 2009;84:526-9.
    PubMed     Text format     Related articles   
    
    
    July 2009
15. CANDONI A , Simeone E, Tiribelli M, Malagola M, et al
    FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
16. LEE SH , Paietta E, Racevskis J, Wiernik PH, et al
    Complete resolution of leukemia cutis with sorafenib in an acute myeloid leukemia patient with FLT3-ITD mutation.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
17. PRETZ J , Medeiros BC
    Thalidomide-induced pneumonitis in a patient with plasma cell leukemia: No recurrence with subsequent lenalidomide therapy.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
18. SETIA N , Connolly T, Levine W, Pantanowitz L, et al
    Chronic lymphocytic leukemia cytoplasmic inclusions.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
19. AU WY , Hon C, Yau K, Lai WW, et al
    Two cases of monocular visual loss during oral arsenic trioxide therapy of acute promyelocytic leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
20. GALLIPOLI P , Clark A, Leach M
    The evolving management of a rare lymphoproliferative disorder-T-cell prolymphocytic leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
21. LUNGHI M , Riccomagno P, De Paoli L, Vendramin C, et al
    Monitoring of cytomegalovirus reactivation during induction and nontransplant consolidation of acute leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
22. HIRSH R , Giri D, Griffith R, Stone R, et al
    Langerhans cell histiocytosis following acute leukemia in an adult.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    June 2009
23. BAYRAKTAR UD , Barker J, Pereira D, Glick DZ, et al
    An unusual presentation of extramedullary biphenotypic lymphoblastic lymphoma.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
24. CHOWDHURY S , Seropian S, Marks PW
    Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
25. CHAWLA NR , Shapiro J, Sham RL
    Pneumatic tube "pseudo tumor lysis syndrome" in chronic lymphocytic leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
26. PICCIRILLO N , Laurenti L, Chiusolo P, Sora F, et al
    Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis.
    Am J Hematol. 2009;84:381-2.
    PubMed     Text format     Related articles   
    
    
    May 2009
27. GATTONI-CELLI S , Buckner CL, Lazarchick J, Stuart RK, et al
    Overexpression of nucleolin in engrafted acute myelogenous leukemia cells.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
28. FERRARA F , Criscuolo C, Riccardi C, Izzo T, et al
    FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
29. FORONI L , Gerrard G, Nna E, Khorashad JS, et al
    Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. LE Y , Xu L, Lu J, Fang J, et al
    FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells.
    Am J Hematol. 2009;84:273-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. BAIN B , Uprichard J
    The value of looking at smear cells.
    Am J Hematol. 2009;84:294.
    PubMed     Text format     Related articles   
    
    
    April 2009
32. LIU J , Mi Y, Fu M, Yu W, et al
    Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. FORGHIERI F , Rossi G, Potenza L, Morselli M, et al
    Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
34. LEE SH , Abebe L, Paietta E, Einzig A, et al
    Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    March 2009
35. ZOTA V , Braza J, Pantanowitz L, Dezube BJ, et al
    A 57-year-old HIV-positive man with persistent fever, weight loss, and pancytopenia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
36. USTUN C , Jillella AP, Salama ME
    Dasatinib induces complete cytogenetic response and loss of F359C in an imatinib resistant chronic myelocytic leukemia patient.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
37. MATULIC M , Paradzik M, Cicin-Sain L, Kapitanovic S, et al
    Ikaros family transcription factors in chronic and acute leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
38. STRUNK CJ , Platzbecker U, Thiede C, Schaich M, et al
    Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics.
    Am J Hematol. 2009;84:308-309.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. NOULSRI E , Richardson DR, Lerdwana S, Fucharoen S, et al
    Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells.
    Am J Hematol. 2009;84:170-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. DIEZ-CAMPELO M , Perez-Simon JA, Perez J, Alcoceba M, et al
    Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies.
    Am J Hematol. 2009;84:149-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
41. PAVLOVSKY C , Kantarjian H, Cortes JE
    First-line therapy for chronic myeloid leukemia: Past, present, and future.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. YASUKAWA M , Fujiwara H, Ochi T, Suemori K, et al
    Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
43. HWANG YY , Tse E, So JC, Wan TS, et al
    Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
44. MIZOGUCHI Y , Fujita N, Taki T, Hayashi Y, et al
    Juvenile myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98-HOXA11 fusion.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. KEANE C , Colreavy M, Lynch M, O'Gorman P, et al
    Aspergillus flavus sinusitis in ALL.
    Am J Hematol. 2009;84:123.
    PubMed     Text format     Related articles   
    
    
    
46. CUNNINGHAM JM , Patnaik MM, Hammerschmidt DE, Vercellotti GM, et al
    Historical perspective and clinical implications of the Pelger-Huet cell.
    Am J Hematol. 2009;84:116-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
47. VERMA D , Fava C, Kantarjian H, Cortes J, et al
    Complexity of BCR-ABL kinase domain mutations during the course of therapy with tyrosine kinase inhibitors in chronic myeloid leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles   
    
    
    
48. MCGREGOR BA , Brown AW, Osswald MB, Savona MR, et al
    The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
    Am J Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
49. KIM H , Park JH, Lee JH, Lee JH, et al
    Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: A prospective, multicenter phase II study.
    Am J Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. GESUNDHEIT B , Shapira MY, Resnick IB, Amar A, et al
    Successful cell-mediated cytokine-activated immunotherapy for relapsed acute myeloid leukemia after hematopoietic stem cell transplantation.
    Am J Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. CHENG Y , Wang H, Wang H, Chen Z, et al
    Trisomy 21 in patients with acute leukemia.
    Am J Hematol. 2008.
    PubMed     Text format     Related articles   
    
    
    
52. GROVES MJ , Maccallum S, Boylan MT, Coates PJ, et al
    The annexin-V assay reflects susceptibility to in vitro membrane damage in chronic lymphocytic leukemia and may overestimate cell death.
    Am J Hematol. 2008.
    PubMed     Text format     Related articles   
    
    
    
53. DEEREN D
    Treatment of invasive aspergillosis with nonmyeloablative allogeneic stem cell transplantation: the hunter becomes the hunted.
    Am J Hematol. 2008;83:939-40.
    PubMed     Text format     Related articles   
    
    
    
54. KLCO JM , Kreisel FH, Zehnbauer BA, Kulkarni S, et al
    The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
    Am J Hematol. 2008;83:901-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
55. AYALA RM , Martinez-Lopez J, Albizua E, Diez A, et al
    Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia.
    Am J Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. CHEN CC , Gau JP, You JY, Lee KD, et al
    Prognostic significance of beta-catenin and topoisomerase IIalpha in de novo acute myeloid leukemia.
    Am J Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. RALLIS E , Stavropoulou E, Michalakeas I, Papadakis P, et al
    Monoblastic sarcoma cutis preceding acute monoblastic leukemia.
    Am J Hematol. 2008.
    PubMed     Text format     Related articles   
    
    
    
58. STONE R
    Timed sequential induction chemotherapy in AML: time for reflection.
    Am J Hematol. 2008;83:829-30.
    PubMed     Text format     Related articles   
    
    
    
59. FREY NV , Leid CE, Nowell PC, Tomczak E, et al
    Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality.
    Am J Hematol. 2008;83:846-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
60. USTUN C , Kalla A, Farrow S, DeRemer DL, et al
    Decitabine as "bridge therapy" to a MUD transplant in relapsed AML postautologous stem cell transplantation.
    Am J Hematol. 2008;83:825-7.
    PubMed     Text format     Related articles   
    
    
    
61. KIM SY , Lee DG, Kim MS, Kim HJ, et al
    The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease.
    Am J Hematol. 2008;83:784-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. KAO JM , McMillan A, Greenberg PL
    International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
    Am J Hematol. 2008;83:765-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
63. GATTENLOHNER S , Volker HU, Etschmann B, Einsele H, et al
    BCR-ABL positive chronic myeloid leukemia with concurrent JAK2(V617F) positive myelodysplastic syndrome/myeloproliferative neoplasm (RARS-T).
    Am J Hematol. 2008.
    PubMed     Text format     Related articles   
    
    
    
64. KATZEL JA , Kempin SJ, Lagmay-Fuentes P, Cook WA, et al
    Therapy-related leukemia in patients with human immunodeficiency virus infection after treatment for non-Hodgkin lymphoma.
    Am J Hematol. 2008.
    PubMed     Text format     Related articles   
    
    
    
65. MOTOHASHI K , Ito S, Hagihara M, Maruta A, et al
    Cutaneous zygomycosis caused by Cunninghamella bertholletiae in a patient with chronic myelogenous leukemia in blast crisis.
    Am J Hematol. 2008.
    PubMed     Text format     Related articles   
    
    
    
66. HOLTAN SG , Santana-Davila R, Dewald GW, Khetterling RP, et al
    Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
    Am J Hematol. 2008;83:708-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. SATO E , Ohga S, Kuroda H, Yoshiba F, et al
    Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Am J Hematol. 2008;83:721-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
68. KANDA Y , Okamoto S, Tauchi T, Kizaki M, et al
    Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: Does body weight matter?
    Am J Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. SAHU GR , Mishra R, Nagpal JK, Das BR, et al
    Notice of retraction. Alteration of p73 in acute myelogenous leukemia.
    Am J Hematol. 2008;83:691.
    PubMed     Text format     Related articles   
    
    
    
70. MIURA Y , Kami M, Yamada M, Nagamatsu S, et al
    Rapid diffuse alveolar hemorrhage associated with all-trans-retinoic acid and filgrastim.
    Am J Hematol. 2008;83:683.
    PubMed     Text format     Related articles   
    
    
    July 2008
71. KALAYCIO M , Advani A, Pohlman B, Sekeres M, et al
    Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
    Am J Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. STONE RM , Deangelo DJ, Janosova A, Galinsky I, et al
    Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.
    Am J Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: